Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat.

J Pharm Bioallied Sci · 2012 · PMC3283962 · PMID 22368404

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The rhEPO treatment in the CRF animals (CRF+rhEPO group) showed a trend to increased hematologic values (RBC, HTC, and Hb) [ Table 1 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.